Companies / Industrials
LMT
Lockheed Martin
Aerospace & Defense
Aerospace & DefenseAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health56
Growth42
Profitability31
Cash generation68
Balance sheet43
Dilution control95
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-27)11.3%Revenue growth (FY)5.6%Revenue CAGR (3y)4.4%Gross margin10.2%Operating margin10.3%Net margin6.7%Free cash flow margin9.2%R&D / revenue2.7%Stock comp / revenue0.4%Net debt / operating cash flow2.19xCurrent ratio1.09Diluted share count change-2.4%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $67.0B | $66.0B | $67.6B | $71.0B | $75.0B |
| Gross profit | $9.1B | $8.3B | $8.5B | $6.9B | $7.6B |
| Operating income | $9.1B | $8.3B | $8.5B | $7.0B | $7.7B |
| Net income | $6.3B | $5.7B | $6.9B | $5.3B | $5.0B |
| Operating cash flow | $9.2B | $7.8B | $7.9B | $7.0B | $8.6B |
| Capital expenditure | $1.5B | $1.7B | $1.7B | $1.7B | $1.6B |
| Free cash flow | $7.7B | $6.1B | $6.2B | $5.3B | $6.9B |
| R&D | $1.5B | $1.7B | $1.5B | $1.6B | $2.0B |
| Stock-based comp | $227M | $238M | $265M | $277M | $304M |
| Buybacks | $4.1B | $7.9B | $6.0B | $3.7B | $3.0B |
| Dividends | $2.9B | $3.0B | $3.1B | $3.1B | $3.1B |
| Cash | $3.6B | $2.5B | $1.4B | $2.5B | $4.1B |
| Total debt | $11.7B | $15.7B | $17.6B | $20.9B | $22.9B |
| Equity | $11.0B | $9.3B | $6.8B | $6.3B | $6.7B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.